The Middle East and Africa Respiratory Devices market is anticipated to grow at more than 7.69% CAGR from 2026 to 2031.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • CAGR (2026-2031): 7.69
  • Largest Market: Saudi Arabia
  • Fastest Market: United Arab Emirates
  • Format: PDF & Excel
Featured Companies
  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • More...

Market Analysis

Over the last ten years, the respiratory devices market in the Middle East and Africa MEA has undergone substantial development, fueled by a growing need for critical care and a high rate of respiratory illnesses. Mechanical ventilators, oxygen concentrators, and nebulizers have been widely used in hospitals and specialized care facilities, initially targeting emergencies and acute treatments. Eventually, the use of these devices extended into managing chronic respiratory diseases, acknowledging the increasing challenges posed by conditions like chronic obstructive pulmonary disease COPD, asthma, and respiratory issues. Advances in technology have led to the creation of reliable devices that are effective in harsh environments, solutions for home care that are easy to transport, and mobile health units that serve rural or underserved regions. To enhance safety, quality, and procurement processes, regulatory bodies like the Saudi Food and Drug Authority SFDA, GCC standards, and World Health Organization preapproval have played an essential role, boosting trust among healthcare professionals. The focus on partnerships between public and private sectors, along with improvements in infrastructure and hospital upgrades, has fostered a setting that encourages more widespread use of respiratory devices. The combination of increased healthcare awareness, population growth in urban areas, and governmental actions has positioned the MEA area as a promising and key market for regional and international medical device firms. According to the research report, " Middle East and Africa Respiratory Devices Market Research Report, 2031," published by Actual Market Research, the Middle East and Africa Respiratory Devices market is anticipated to grow at more than 7.69% CAGR from 2026 to 2031. The respiratory devices market in MEA has shown consistent growth, bolstered by investments from both the public and private sectors. The recent growth of hospitals, intensive care departments, and specialized respiratory facilities has increased the need for ventilators, continuous positive airway pressure CPAP machines, and advanced oxygen therapy equipment. Major industry players such as GE Healthcare, Dräger, and local vendors are forming alliances and building distribution channels to meet rising demand.

New potential in the MEA region is closely tied to healthcare advancement projects, medical tourism, and government funding aimed at improving critical care settings. As urban populations expand and healthcare access becomes more available, hospitals are needing more advanced technology that allows them to provide effective treatment while shortening time of care. Furthermore, mobile healthcare technologies and portable devices are essential for managing patients remotely, particularly in rural or conflict-hit regions. The healthcare environment in the region is also embracing digital monitoring and telemedicine innovations, contributing to better patient outcomes and greater operational efficiency. With governments continuing to focus on healthcare development and readiness for pandemics, the MEA respiratory devices market is projected to maintain robust growth, offering both local and suppliers a vibrant landscape for creativity, collaboration, and market entry. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Growing occurrence of respiratory illnesses: Respiratory illnesses such as asthma, COPD, and pneumonia are on the rise in the MEA area. Elements like air pollution, factory emissions, tobacco consumption, and urban growth are contributing to these health issues. The increase in both chronic and contagious respiratory ailments boosts the demand for diagnostic and treatment respiratory devices. Advanced equipment like ventilators, nebulizers, and oxygen concentrators are required by hospitals, clinics, and homecare settings. The necessity for early diagnosis and treatment also drives the need for monitoring devices. This expanding patient population guarantees ongoing market expansion.

• Rising expenditure on healthcare and development of infrastructure: Nations like the UAE, Saudi Arabia, and South Africa are making significant investments in healthcare systems. New healthcare facilities, clinics, and specialized centers for respiratory care are being established. Funding from both public and private sectors aids in acquiring state-of-the-art medical devices. Enhanced healthcare coverage and insurance policies further motivate the adoption of new devices. Increasing financial allocations for healthcare enable healthcare providers to purchase advanced and superior respiratory equipment. Better infrastructure also enhances patient access to medical services. Market Challenges

• High price of advanced devices: Numerous respiratory devices, particularly ventilators and intelligent monitoring systems, come at a high price. This expense limits access for patients in economically disadvantaged regions. Healthcare facilities might postpone equipment upgrades due to financial limitations. Such delays hinder the adoption of the latest advancements and cause inequalities in healthcare provision. Individuals in isolated or rural locations may face restrictions in accessing these devices. Cost stands out as a significant obstacle to market growth in the MEA area.

• Insufficient awareness and correct usage: A considerable number of patients and caregivers lack comprehensive knowledge about respiratory diseases and how to use devices properly. Incorrect or irregular use diminishes the effectiveness of treatment. Training and educational initiatives are scarce in some regions. A deficit in understanding can result in adverse health outcomes, repeated hospital admissions, and heightened healthcare expenses. Publicity efforts and accurate training are crucial to guarantee that devices are used properly. Market Trends

• Homecare and portable devices: There is an increasing inclination towards home-based care due to its convenience and financial savings. Portable tools like oxygen concentrators, nebulizers, and CPAP machines are becoming more widely used. Patients are able to manage chronic illnesses without frequent hospital trips. Remote monitoring gadgets enhance homecare, supporting adherence to prescribed treatments. Healthcare professionals are backing homecare initiatives to lessen the burden on hospitals. This trend is projected to persist as urban populations increase.

• Incorporation of intelligent technologies: Smart devices featuring AI and IoT capabilities are being integrated into respiratory care. These gadgets permit remote monitoring, immediate data collection, and automated notifications for unusual readings. Patients can send their data to physicians for prompt interventions. Intelligent technologies enhance the precision of treatments and encourage patient compliance. The combination of software platforms with devices improves disease management processes. This trend is consistent with the digital advancements in the healthcare sector within the MEA region.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Segmentation

By Product Type Therapeutic Devices
Monitoring Devices
Diagnostic Devices
Consumables and Accessories
By Disease Indication Chronic Obstructive Pulmonary disease (COPD)
Sleep Apnea
Asthma
Infectious Diseases
Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)
By End User Hospitals
Ambulatory Care Centers (ACCs)
Home care Settings
Other End User
MEA North America
Europe
Asia-Pacific
South America
MEA



Therapeutic devices are the key segment in the MEA respiratory devices market because of the widespread occurrence of chronic respiratory illnesses and a rise in hospital treatments in this area.

In the market for respiratory devices in the Middle East and Africa MEA, therapeutic devices are experiencing remarkable growth, making up the largest portion. This trend is mainly influenced by the rising incidence of chronic lung diseases like asthma, chronic obstructive pulmonary disease COPD, and lung infections. Factors such as rapid urban growth, increasing pollution levels, and exposure to environmental triggers in MEA nations have resulted in more cases of these illnesses, which necessitate ongoing therapeutic care. Hospitals and specialized healthcare facilities are putting more resources into modern therapeutic devices, such as nebulizers, inhalers, and ventilators, to deliver quality patient treatment and handle both acute and chronic respiratory issues. Governmental efforts to enhance healthcare systems, along with growing understanding among patients about the importance of early intervention, have boosted the demand for these therapeutic devices. The cost-effectiveness and easy access to these devices in urban areas, along with expanded insurance coverage in various nations, further support their leading status. The therapeutic segment enjoys consistent usage trends, as patients dealing with chronic illnesses depend on these devices for long periods, ensuring a reliable need. The ongoing introduction of innovative products that feature better performance and user-friendly designs has also helped secure the segment’s top rank. The mix of increasing disease rates, improved healthcare accessibility, and heightened patient awareness solidifies therapeutic devices as the largest and most stable segment in the MEA respiratory devices market.

COPD constitutes the largest portion of the MEA respiratory devices market as a result of its widespread occurrence, driven by factors like smoking, air contamination, and job-related risks in the area.

Chronic Obstructive Pulmonary Disease COPD holds the top position in the respiratory devices market across the Middle East and Africa MEA due to various environmental, lifestyle, and population-related influences. The number of COPD cases in MEA nations is consistently increasing, largely due to the prevalence of smoking, rising levels of urban air pollution, and exposure to workplace and industrial pollutants. Furthermore, using biomass fuels for cooking and heating in less urbanized areas greatly contributes to respiratory health issues, leading to a high incidence of COPD as a chronic illness in this region. This condition typically necessitates ongoing management, resulting in a steady need for respiratory devices such as inhalers, nebulizers, and oxygen delivery systems. Hospitals, clinics, and homecare facilities are progressively being outfitted with these therapeutic and monitoring devices to alleviate symptoms and avert worsening of the disease. Awareness initiatives, government health programs, and efforts to enhance access to modern medical devices have significantly improved utilization rates among patients with COPD. The long-lasting nature of this disease, along with frequent hospital admissions and the requirement for continuous treatment, assures a constant need for respiratory devices. Advances in medication delivery systems, including portable inhalers and sophisticated nebulizers, further bolster the market for devices related to COPD. , the convergence of high disease incidence, environmental risk elements, and enhancing healthcare availability cements COPD's status as the leading disease indication segment in the MEA respiratory devices market.

Hospitals hold the largest end-user segment in the MEA respiratory devices market because of the high volume of patients, the need for critical care, and their sophisticated systems for addressing chronic and acute respiratory issues.

Hospitals constitute the primary end-user segment in the Middle East and Africa MEA respiratory devices market as they are the main facilities for diagnosing, treating, and managing respiratory disorders. This region has seen a consistent rise in chronic respiratory ailments such as COPD, asthma, and lung infections, along with acute respiratory incidents triggered by factors like pollution, smoking, and workplace risks. Hospitals are outfitted with state-of-the-art therapeutic and monitoring equipment, such as ventilators, nebulizers, oxygen delivery systems, and diagnostic instruments, which are vital in handling both critical and long-term respiratory situations. The growing number of intensive care units ICUs and dedicated pulmonary departments in urban locations enhances the demand for respiratory devices used in hospitals. Furthermore, hospitals frequently act as referral points for patients coming from rural or semi-urban regions, which ensures steady use of equipment and a high turnover of patients. Government efforts to strengthen healthcare infrastructure, investments in cutting-edge medical devices, and the adoption of care standards have reinforced hospitals’ position as a leading end-user category. Hospitals offer expert monitoring and maintenance for these devices, leading to improved patient results and increasing trust in these environments. The combination of a large influx of patients, complex treatment requirements, and the availability of advanced respiratory care technologies results in hospitals being the leading end-user segment in the MEA respiratory devices market.

Market Regional Insights


Saudi Arabia holds the top position in the MEA respiratory devices sector due to its sophisticated healthcare system, substantial government funding for health services, and an increase in respiratory disease cases.

Saudi Arabia stands at the forefront of the respiratory devices market in the Middle East and Africa MEA region, driven by a mix of a robust healthcare framework, governmental aid, and a growing incidence of respiratory health issues. The nation has heavily invested in upgrading its healthcare facilities, including hospitals, specialty care centers, and ICUs, which aids in the implementation of advanced respiratory equipment like ventilators, nebulizers, and oxygen systems. Government programs, such as the Saudi Vision 2030, prioritize enhancing healthcare access, boosting public awareness, and integrating modern medical technologies, significantly impacting the country’s market leadership. The rise in chronic respiratory conditions like asthma, COPD, and lung infections is fueled by urban growth, environmental pollution, tobacco use, and lifestyle habits. This escalating health crisis leads to a steady demand for both treatment and monitoring respiratory devices in hospital and home care environments. Saudi Arabia also enjoys a higher healthcare spending per capita compared to other nations in the MEA, allowing medical providers to invest in state-of-the-art respiratory technology. Furthermore, established supply networks, collaborations with international medical device manufacturers, and regulatory conditions that support the import and use of cutting-edge devices bolster the market's strength. The existence of training programs for medical practitioners guarantees that these devices are used effectively, improving patient results and driving market expansion. A blend of governmental support, a strong healthcare foundation, a rising number of respiratory diseases, and the adoption of technology positions Saudi Arabia as the leading market for respiratory devices in the MEA region.

Companies Mentioned

  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • 7 . Stryker corporation
  • 8 . Siemens AG
  • 9 . GE Healthcare
  • 10 . Vapotherm Inc.
  • 11 . Dragerwerk AG & Co. KGaA
  • 12 . Juki Corporation
  • 13 . Nidek Medical Products Inc.
  • 14 . Besco Medical Limited

Table of Contents

  • Table 1: Influencing Factors for Respiratory Devices Market, 2025
  • Table 2: Top 10 Counties Economic Snapshot 2024
  • Table 3: Economic Snapshot of Other Prominent Countries 2022
  • Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 5: Middle East & Africa Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 6: Middle East & Africa Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 7: Middle East & Africa Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 8: United Arab Emirates (UAE) Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 9: United Arab Emirates (UAE) Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 10: Saudi Arabia Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 11: Saudi Arabia Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 12: South Africa Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 13: South Africa Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 14: Competitive Dashboard of top 5 players, 2025

  • Figure 1: Middle East & Africa Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 2: Middle East & Africa Respiratory Devices Market Share By Country (2025)
  • Figure 3: United Arab Emirates (UAE) Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 4: Saudi Arabia Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 5: South Africa Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 6: Porter's Five Forces of Global Respiratory Devices Market

Market Research FAQs

Saudi Arabia is among the largest market in the region due to their well-developed healthcare infrastructure and higher healthcare expenditure.
Limited access to advanced healthcare in some areas, especially in rural regions, the cost of respiratory care devices, and lack of awareness and education about respiratory diseases and their management can hinder early diagnosis and treatment.
The market is expected to continue growing due to the rising burden of respiratory diseases and the increasing awareness of the importance of early diagnosis and treatment. Technological advancements and the adoption of telemedicine are likely to further shape the market's future.
The COVID-19 pandemic has led to an increased demand for respiratory care devices, especially ventilators and oxygen concentrators, to manage severe cases of the disease. This has highlighted the importance of a robust healthcare infrastructure and the need for adequate stockpiles of respiratory care devices to handle potential healthcare crises in the future.
Middle East respiratory syndrome–related coronavirus, or EMC/2012, is the virus that causes Middle East respiratory syndrome. It is a species of coronavirus which infects human.
The primary factors for growth include the rising incidence of respiratory illnesses such as asthma, COPD, and pneumonia, along with increased healthcare funding and improvements.
Major challenges consist of the high prices of advanced respiratory devices, low patient knowledge and training regarding device operation, and inadequate access to healthcare services.
Homecare and portable devices, like oxygen concentrators, nebulizers, CPAP machines, and smart monitoring tools, are gaining traction due to their convenience and technological advancements.
Smart technologies, such as AI, IoT, and remote monitoring, enhance management of diseases, adherence to treatments, and overall patient results, making devices more effective and user-friendly.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags